Selectis Health (GBCS)
OTHER OTC:GBCS
US Market
Holding GBCS?
Track your performance easily

Selectis Health (GBCS) Technical Analysis

1 Followers

Summary of all the Indicators

Overall Consensus
Sell
5Bullish
6Neutral
11Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Selectis Health’s (GBCS) Moving Averages Convergence Divergence (MACD) indicator is 0.05, suggesting Selectis Health is a Sell.
Selectis Health’s (GBCS) 20-Day exponential moving average is 2.23, while Selectis Health’s (GBCS) share price is $2.49, making it a Buy.
Selectis Health’s (GBCS) 50-Day exponential moving average is 2.19, while Selectis Health’s (GBCS) share price is $2.49, making it a Buy.

Selectis Health (GBCS) Pivot Points

Jul 31, 2024, 08:23 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.50
1.75
2.00
2.25
2.50
2.75
3.00
Fibonacci
1.75
1.94
2.06
2.25
2.44
2.56
2.75
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Selectis Health (GBCS) Moving Averages

Jul 31, 2024, 08:23 PM
Period
Simple
Exponential
MA5
2.30Sell
2.27Sell
MA10
2.27Sell
2.27Sell
MA20
2.25Sell
2.23Buy
MA50
2.18Buy
2.19Buy
MA100
2.02Buy
2.33Sell
MA200
2.96Sell
2.94Sell
Selectis Health’s (GBCS) 10-Day exponential moving average is 2.27, while Selectis Health’s (GBCS) share price is $2.49, making it a Sell.
Selectis Health’s (GBCS) 100-Day exponential moving average is 2.33, while Selectis Health’s (GBCS) share price is $2.49, making it a Sell.
Selectis Health’s (GBCS) stock price is $2.49 and Selectis Health’s (GBCS) 50-day simple moving average is 2.18, creating a Buy signal.
Selectis Health’s (GBCS) stock price is $2.49 and Selectis Health’s (GBCS) 100-day simple moving average is 2.02, creating a Buy signal.
Selectis Health’s (GBCS) stock price is $2.49 and Selectis Health’s (GBCS) 200-day simple moving average is 2.96, creating a Sell signal.

Selectis Health (GBCS) Technical Indicators

Jul 31, 2024, 08:23 PM
Name
Value
Implied Action
RSI (14)
52.61
Neutral
STOCH (9,6)
50.00
Neutral
STOCHRSI (14)
50.00
Neutral
MACD (12,26)
0.05
Sell
ADX (14)
44.75
Neutral
Williams %R
-50.00
Buy
CCI (14)
10.68
Neutral
ATR (14)
0.45
-
Ultimate Oscillator
54.49
Neutral
ROC
-2.17
Sell
Selectis Health’s (GBCS) Relative Strength Index (RSI) is 52.61, creating a Neutral signal.
Selectis Health’s (GBCS) Trend Strength Indicator (ADX) is 44.75, creating a Neutral signal.
Selectis Health’s (GBCS) Commodity Channel Index (CCI) is 10.68, creating a Neutral signal.
Selectis Health’s (GBCS) Price Rate of Change (ROC) is -2.17, creating a Sell signal.

FAQ

Is GBCS a Buy, Hold, or Sell?
Based on GBCS’s technical indicators, GBCS is a Sell.
    What is GBCS’s RSI (14)?
    GBCS’s RSI (14) is 52.61, which suggests GBCS is a Neutral.
      What is GBCS’s MACD?
      GBCS’s MACD is 0.05, which suggests GBCS is a Sell.
        What is GBCS’s 5-day moving average?
        GBCS’s 5-day moving average is 2.30, which suggests GBCS is a Sell.
          What is GBCS’s 20-day moving average?
          GBCS 20-day moving average is 2.25, which suggests GBCS is a Sell.
            What is GBCS’s 50-day moving average?
            GBCS’s 50-day moving average is 2.18, which suggests GBCS is a Buy.
              What is GBCS’s 200-day moving average?
              GBCS’s 200-day moving average is 2.96, which suggests GBCS is a Sell.
                What is GBCS’s Williams % R (14)?
                GBCS’s Williams % R (14) is -50.00, which suggests GBCS is a Buy.
                  What is GBCS’s CCI (14)?
                  GBCS’s CCI (14) is 10.68, which suggests GBCS is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis